Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer

Open access
Moon, Pyong-Gon, Lee, Jeong-Eun, Cho, Young-Eun, Lee, Soo Jung, Chae, Yee Soo, Jung, Jin Hyang, Kim, In-San, Park, Ho Yong, Baek, Moon-Chang·2016·Oncotarget

Abstract

// Pyong-Gon Moon 1 , Jeong-Eun Lee 1 , Young-Eun Cho 1 , Soo Jung Lee 2 , Yee Soo Chae 2 , Jin Hyang Jung 3 , In-San Kim 4 , Ho Yong Park 3 , Moon-Chang Baek 1 1 Department of Molecular Medicine, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea 2 Department of Oncology/Hematology, Kyungpook National University Hospital, Daegu 700-721, Republic of Korea 3 Department of Breast & Thyroid Surgery, Kyungpook National University Hospital, Daegu 700-721, Republic of Korea 4 Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, KU-KIST School, Korea University, Seoul 02841, Republic of Korea Correspondence to: Moon-Chang Baek, email: mcbaek@knu.ac.kr Keywords: breast cancer, diagnosis, extracellular vesicle, ELISA Received: September 15, 2015 Accepted: May 02, 2016 Published: May 23, 2016 ABSTRACT Extracellular vesicles (EVs) secreted from cancer cells have potential for generating cancer biomarker signatures. Fibronectin (FN) was selected as a biomarker candidate, due to the presence in surface on EVs secreted from human breast cancer cell lines. A subsequent study used two types of enzyme-linked immunosorbent assays (ELISA) to determine the presence of these proteins in plasma samples from disease-free individuals (n=70), patients with BC (n=240), BC patients after surgical resection (n=40), patients with benign breast tumor (n=55), and patients with non-cancerous diseases (thyroiditis, gastritis, hepatitis B, and rheumatoid arthritis; n=80). FN levels were significantly elevated (p< .0001) at all stages of BC, and returned to normal after tumor removal. The diagnostic accuracy for FN detection in extracellular vesicles (ELISA method 1) (area under the curve, 0.81; 95% CI, 0.76 to 0.86; sensitivity of 65.1% and specificity of 83.2%) were also better than those for FN detection in the plasma (ELISA method 2) (area under the curve, 0.77; 95% CI, 0.72 to 0.83; sensitivity of 69.2% and specificity of 73.3%) in BC. The diagnostic accuracy of plasma FN was similar in both the early-stage BC and all BC patients, as well as in the two sets. This liquid biopsy to detect FN on circulating EVs could be a promising method to detect early breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.9561

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 193

Metadata

Authors
Moon, P.-G., Lee, J.-E., Cho, Y.-E., Lee, S. J., Chae, Y. S., Jung, J. H., Kim, I.-S., Park, H. Y., & Baek, M.-C.
Venue
Oncotarget
Published
2016-05-23
Volume
7
Issue
26
Pages
40189-40199
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2396935220
Cited by
193
References
8
FWCI
6.17
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.